Back to top

Image: Bigstock

Nutrisystem Declares Multi-Brand Marketing Approach for '17

Read MoreHide Full Article

Weight management products and service provider Nutrisystem Inc. announced that it will focus on a multi-brand marketing approach with two new distinct programs – Nutrisystem Lean13 and the South Beach Diet – in 2017.

A glimpse at the stock price movement reveals a solid trend as Nutrisystem gained almost 43.99% over the last six months, compared with the Zacks categorized Consumer Products-Discretionary sub-industry’s gain of roughly 6.66% and the S&P 500’s return of 10.50%.

Notably, the estimate revision trend for the current year seems favorable, with two upward revisions in the last three months and no downward revision. Notably, the current-year estimates for the stock inched up 3 cents to $1.27 per share, over the past three months.



The company’s marketing approach will focus on its flagship Nutrisystem brand which comes with the clinically-tested Nutrisystem Lean13 program. Management, in a prudent move, made Nutrisystem available at Walmart stores nationwide and other regional retail outlets with 5-day weight loss kits in several varieties such as Jumpstart, Protein Powered, Homestyle, and Diabetic. Additionally, Nutrisystem has a line of individual products including NutriCrush Bars and Shakes, Sweet and Savory Snacks, and lunch items such as Thick Crust Pizza. This we feel will help in further market penetration in 2017.

Similarly the South Beach Diet brand will be positioned as a structured meal delivery weight-loss program. It would also be positioned as a distinct offering with its own unique look and feel, supported by a 360-degree marketing campaign, including television, online, print, and digital advertisements, which will begin rolling out in Jan 2017.

NutriSystem is a leading provider of weight management products and services. The company offers an at-home weight loss program based on portion-controlled, lower Glycemic Index prepared meals, weight loss plans, and private telephone and online support.

Zacks Rank & Key Picks

Currently, Nutrisystem has a Zacks Rank #3 (Hold).

Better-ranked medical stocks include NxStage Medical Inc. , Align Technology, Inc. (ALGN - Free Report) and Haemonetics Corporation (HAE - Free Report) . NxStage Medical and Align Technology sport a Zacks Rank #1 (Strong Buy) while Haemonetics carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

NxStage Medical gained 14.4% over the last one year compared with the S&P 500’s 9% growth. The company has a four-quarter average positive earnings surprise of 46.3%.

Align Technology rallied 47% year to date, way better than the S&P 500’s 10.1%. It has a trailing four-quarter average positive earnings surprise of 23%.

Haemonetics recorded a 23.7% gain year to date, better than the S&P 500. It has a trailing four-quarter average positive earnings surprise of 0.82%.

Zacks' Top Investment Ideas for Long-Term Profit

How would you like to see our best recommendations to help you find today’s most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Click here >>


Unique Zacks Analysis of Your Chosen Ticker


Pick one free report - opportunity may be withdrawn at any time


Align Technology, Inc. (ALGN) - $25 value - yours FREE >>

Haemonetics Corporation (HAE) - $25 value - yours FREE >>

Published in